DK3487505T3 - Indgivelse og dosering af diaminophenothiaziner - Google Patents
Indgivelse og dosering af diaminophenothiaziner Download PDFInfo
- Publication number
- DK3487505T3 DK3487505T3 DK17743330.7T DK17743330T DK3487505T3 DK 3487505 T3 DK3487505 T3 DK 3487505T3 DK 17743330 T DK17743330 T DK 17743330T DK 3487505 T3 DK3487505 T3 DK 3487505T3
- Authority
- DK
- Denmark
- Prior art keywords
- diaminophenothiazines
- dosage
- administration
- Prior art date
Links
- KPYHKEZPEDJERZ-UHFFFAOYSA-N 10h-phenothiazine-1,2-diamine Chemical class C1=CC=C2NC3=C(N)C(N)=CC=C3SC2=C1 KPYHKEZPEDJERZ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2203/00—Decoration means, markings, information elements, contents indicators
- B65D2203/02—Labels
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Mycology (AREA)
- Psychology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Composite Materials (AREA)
- Botany (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mechanical Engineering (AREA)
- Physiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1612863.9A GB201612863D0 (en) | 2016-07-25 | 2016-07-25 | Administration and dosage of diaminophenothiazines |
| GBGB1710382.1A GB201710382D0 (en) | 2017-06-29 | 2017-06-29 | Administration and dosage of Diaminophenothiazines |
| PCT/EP2017/068749 WO2018019823A1 (en) | 2016-07-25 | 2017-07-25 | Administration and dosage of diaminophenothiazines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3487505T3 true DK3487505T3 (da) | 2023-05-30 |
Family
ID=59399428
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17743330.7T DK3487505T3 (da) | 2016-07-25 | 2017-07-25 | Indgivelse og dosering af diaminophenothiaziner |
| DK23212899.1T DK4335517T3 (da) | 2016-07-25 | 2017-07-25 | Indgivelse og dosering af diaminofenothiaziner |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK23212899.1T DK4335517T3 (da) | 2016-07-25 | 2017-07-25 | Indgivelse og dosering af diaminofenothiaziner |
Country Status (18)
| Country | Link |
|---|---|
| US (5) | US11065256B2 (da) |
| EP (3) | EP4335517B8 (da) |
| JP (1) | JP7073330B2 (da) |
| KR (4) | KR20230058533A (da) |
| CN (2) | CN109789148A (da) |
| AU (3) | AU2017301966B2 (da) |
| CA (1) | CA3031578C (da) |
| DK (2) | DK3487505T3 (da) |
| ES (2) | ES2946165T3 (da) |
| FI (2) | FI4335517T3 (da) |
| HR (2) | HRP20230628T1 (da) |
| MX (2) | MX385594B (da) |
| MY (2) | MY210565A (da) |
| PL (1) | PL3487505T3 (da) |
| PT (2) | PT4335517T (da) |
| SG (1) | SG11201900228YA (da) |
| SI (2) | SI3487505T1 (da) |
| WO (1) | WO2018019823A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007274057B2 (en) | 2006-07-11 | 2012-12-13 | TauRx Therapeutics Management Ltd | Methods of synthesis and/or purification of diaminophenothiazinium compounds |
| CN109789148A (zh) | 2016-07-25 | 2019-05-21 | 维斯塔实验室有限公司 | 二氨基吩噻嗪的给药和剂量 |
| ES2989458T3 (es) | 2018-07-26 | 2024-11-26 | Wista Lab Ltd | Dosis optimizada de diaminofenotiazinas en poblaciones |
| AU2018440060B2 (en) | 2018-09-05 | 2025-04-10 | Genting Taurx Diagnostic Centre Sdn Bhd | Network methods for neurodegenerative diseases |
| MY209608A (en) * | 2019-04-10 | 2025-07-24 | Genting Taurx Diagnostic Centre Sdn Bhd | Adaptive neurological testing method |
| GB201909454D0 (en) | 2019-07-01 | 2019-08-14 | Wista Lab Ltd | Enhancers |
| GB201909493D0 (en) * | 2019-07-01 | 2019-08-14 | Wista Lab Ltd | Therapeutic interactions |
| GB201909506D0 (en) * | 2019-07-02 | 2019-08-14 | Wista Lab Ltd | Synaptopathies |
| EP4146225B1 (en) * | 2020-05-05 | 2024-10-09 | WisTa Laboratories Ltd. | Methylthioninium compounds for use in the treatment of hypoxemia |
| GB202006659D0 (en) * | 2020-05-05 | 2020-06-17 | Wista Lab Ltd | Therapeutic treatments |
| AU2023279800A1 (en) | 2022-05-31 | 2024-12-19 | TauRx Therapeutics Management Ltd | Treatment of neurodegenerative disorders utilising methylthioninium (mt)-containing compounds |
| WO2024061971A1 (en) | 2022-09-21 | 2024-03-28 | Wista Laboratories Ltd. | Novel formulations and vehicles |
| WO2024184146A1 (en) | 2023-03-03 | 2024-09-12 | Wista Laboratories Ltd. | Diaminophenothiazine for the treatment of microvascular brain disease disease |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9506197D0 (en) | 1995-03-27 | 1995-05-17 | Hoffmann La Roche | Inhibition of tau-tau association. |
| GB0100119D0 (en) | 2001-01-03 | 2001-02-14 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| GB0101049D0 (en) | 2001-01-15 | 2001-02-28 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| GB0106953D0 (en) | 2001-03-20 | 2001-05-09 | Univ Aberdeen | Neufofibrillary labels |
| WO2003101458A1 (en) | 2002-05-31 | 2003-12-11 | H. Lundbeck A/S | A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease |
| PT2322517T (pt) | 2004-09-23 | 2019-07-30 | Wista Lab Ltd | Métodos de síntese química e purificação de compostos de diaminofenotiazínio incluindo cloreto de metiltionínio (mtc) |
| MY172157A (en) | 2006-03-29 | 2019-11-15 | Wista Lab Ltd | Thioninium compounds and their use |
| KR100983301B1 (ko) | 2006-03-29 | 2010-09-20 | 위스타 레보레이토리스 리미티드 | 3,7―다이아미노―10h―페노티아진염 및 이의 용도 |
| PL2004155T3 (pl) * | 2006-03-29 | 2018-08-31 | Wista Laboratories Ltd. | Inhibitory agregacji białek |
| AU2007274057B2 (en) | 2006-07-11 | 2012-12-13 | TauRx Therapeutics Management Ltd | Methods of synthesis and/or purification of diaminophenothiazinium compounds |
| FR2903696B1 (fr) | 2006-07-12 | 2011-02-11 | Provence Technologies | Procede de purification de composes diaminophenothiazium |
| PL2167095T3 (pl) * | 2007-06-19 | 2019-11-29 | Wista Lab Ltd | Związki fenotiazynowe do leczenia łagodnych zaburzeń poznawczych |
| EP2954932B1 (en) | 2007-10-03 | 2018-09-19 | WisTa Laboratories Ltd. | Therapeutic use of diaminophenothiazines |
| WO2009060191A2 (en) | 2007-11-05 | 2009-05-14 | Wista Laboratories Ltd. | Systems for clinical trials |
| WO2010078659A1 (en) | 2009-01-12 | 2010-07-15 | Foster Health Inc. | Compositions and methods for nutritional prevention and treatment of alzheimer's-associated conditions |
| WO2010104375A1 (en) | 2009-03-12 | 2010-09-16 | N.V. Nutricia | Stigmasterol for the treatment of alzheimer's disease |
| MX2012003035A (es) | 2009-09-24 | 2012-06-12 | Wista Lab Ltd | Proceso. |
| BR112012006638B1 (pt) | 2009-09-24 | 2020-05-26 | Wista Laboratories Ltd. | Forma c de di-hidrato de cloreto de metiltionínio, seu processo de preparação, e composição farmacêutica |
| DE102010062810B4 (de) | 2010-09-07 | 2014-03-13 | Immungenetics Ag | 2-(R2-Thio)-10-[3-(4-R1-piperazin-1-yl)propyl]-10H-phenothiazine zur Behandlung neurodegenerativer Erkrankungen ausgewählt aus beta-Amyloidopathien und alpha-Synucleinopathien |
| SG10201602111VA (en) | 2010-11-30 | 2016-04-28 | Wista Lab Ltd | Formulations Comprising Methylthioninium Chloride |
| JP5898701B2 (ja) * | 2011-02-11 | 2016-04-13 | ウィスタ ラボラトリーズ リミテッド | フェノチアジンジアミニウム塩およびそれらの使用 |
| CN109789148A (zh) * | 2016-07-25 | 2019-05-21 | 维斯塔实验室有限公司 | 二氨基吩噻嗪的给药和剂量 |
| GB201614834D0 (en) | 2016-09-01 | 2016-10-19 | Wista Lab Ltd | Treatment of dementia |
| ES2989458T3 (es) | 2018-07-26 | 2024-11-26 | Wista Lab Ltd | Dosis optimizada de diaminofenotiazinas en poblaciones |
| GB201909493D0 (en) | 2019-07-01 | 2019-08-14 | Wista Lab Ltd | Therapeutic interactions |
-
2017
- 2017-07-25 CN CN201780058028.2A patent/CN109789148A/zh active Pending
- 2017-07-25 SG SG11201900228YA patent/SG11201900228YA/en unknown
- 2017-07-25 EP EP23212899.1A patent/EP4335517B8/en active Active
- 2017-07-25 MY MYPI2023002755A patent/MY210565A/en unknown
- 2017-07-25 KR KR1020237013185A patent/KR20230058533A/ko not_active Ceased
- 2017-07-25 DK DK17743330.7T patent/DK3487505T3/da active
- 2017-07-25 HR HRP20230628TT patent/HRP20230628T1/hr unknown
- 2017-07-25 KR KR1020227042657A patent/KR102592614B1/ko active Active
- 2017-07-25 US US16/320,148 patent/US11065256B2/en active Active
- 2017-07-25 SI SI201731376T patent/SI3487505T1/sl unknown
- 2017-07-25 KR KR1020247016105A patent/KR20240074909A/ko not_active Ceased
- 2017-07-25 AU AU2017301966A patent/AU2017301966B2/en active Active
- 2017-07-25 PT PT232128991T patent/PT4335517T/pt unknown
- 2017-07-25 ES ES17743330T patent/ES2946165T3/es active Active
- 2017-07-25 WO PCT/EP2017/068749 patent/WO2018019823A1/en not_active Ceased
- 2017-07-25 PL PL17743330.7T patent/PL3487505T3/pl unknown
- 2017-07-25 PT PT177433307T patent/PT3487505T/pt unknown
- 2017-07-25 EP EP23165202.5A patent/EP4223297A3/en active Pending
- 2017-07-25 JP JP2019501700A patent/JP7073330B2/ja active Active
- 2017-07-25 CN CN202310423724.6A patent/CN116531386A/zh active Pending
- 2017-07-25 ES ES23212899T patent/ES3046673T3/es active Active
- 2017-07-25 HR HRP20251365TT patent/HRP20251365T1/hr unknown
- 2017-07-25 EP EP17743330.7A patent/EP3487505B1/en active Active
- 2017-07-25 MX MX2019000946A patent/MX385594B/es unknown
- 2017-07-25 FI FIEP23212899.1T patent/FI4335517T3/fi active
- 2017-07-25 DK DK23212899.1T patent/DK4335517T3/da active
- 2017-07-25 CA CA3031578A patent/CA3031578C/en active Active
- 2017-07-25 FI FIEP17743330.7T patent/FI3487505T3/fi active
- 2017-07-25 MY MYPI2019000171A patent/MY201804A/en unknown
- 2017-07-25 KR KR1020197005446A patent/KR102475825B1/ko active Active
- 2017-07-25 SI SI201731628T patent/SI4335517T1/sl unknown
-
2019
- 2019-01-22 MX MX2021009899A patent/MX2021009899A/es unknown
-
2021
- 2021-06-16 US US17/349,427 patent/US11759469B2/en active Active
-
2022
- 2022-10-07 US US17/961,765 patent/US12128051B2/en active Active
- 2022-12-19 AU AU2022291420A patent/AU2022291420B2/en active Active
-
2023
- 2023-04-06 US US18/131,570 patent/US12310973B2/en active Active
- 2023-05-17 AU AU2023203084A patent/AU2023203084B2/en active Active
-
2025
- 2025-04-23 US US19/187,936 patent/US20250262219A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK4335517T3 (da) | Indgivelse og dosering af diaminofenothiaziner | |
| DK3506884T4 (da) | Sammensætninger til indgivelse af medicin og anvendelser deraf | |
| DK3212230T3 (da) | Dosering og indgivelse af ikke-fucosylerede anti-CD40-antistoffer | |
| DK3278803T3 (da) | Fast farmaceutisk doseringsform af PARP-inhibitor, og anvendelse af fast farmaceutisk doseringsform af PARP-inhibitor | |
| DK3244948T3 (da) | Bestemmelse af medikamentdosis | |
| DK3302565T3 (da) | Faste doseringsformer af palbociclib | |
| DK3703784T3 (da) | Anordning til indgivelse af lægemidler | |
| DK3302638T3 (da) | Anordning til indgivelse af lægemidler | |
| EP3352757C0 (en) | ADMINISTRATION OF DEUTERIUM-MODIFIED CFTR POTENTIATION AGENTS | |
| DK3357513T3 (da) | Farmaceutisk sammensætning og anvendelse deraf | |
| DK3354282T3 (da) | Glycan-terapeutiske midler og relaterede fremgangsmåder deraf | |
| DK3988117T3 (da) | Terapeutiske antistoffer og deres anvendelser | |
| DK3285831T3 (da) | Underenhed af en medikamenttilførselsanordning og en medikamenttilførselsanordning | |
| PL3362084T3 (pl) | Urządzenia do podawania dojelitowego i powiązane sposoby zastosowania | |
| DK3242947T3 (da) | Genterapi og elektroporese til behandling af maligniteter | |
| DK3331879T3 (da) | Benzazolforbindelser og fremgangsmåder til fremstilling og anvendelse af forbindelserne | |
| DK3514153T3 (da) | Pyrimidinforbindelse og farmaceutisk anvendelse deraf | |
| DK3113782T3 (da) | Lægemiddelleveringssystemer og fremgangsmåder til behandling af blærekræft med gemcitabin | |
| DK3265126T3 (da) | Kombinationsformulering af tesofensin og metoprolol | |
| DK3319609T3 (da) | Sammensætninger og fremgangsmåder til anvendelse af antibakterielle lægemiddelkombinationer | |
| DK3380525T3 (da) | Farmaceutiske formuleringer og fremgangsmåder til anvendelse deraf | |
| DK3297651T3 (da) | Synergistisk kombination af neuronale levedygtighedsfaktorer og anvendelser deraf | |
| EP3526186A4 (en) | SUBSTITUTED HYDROXY STYLENE AND THEIR THERAPEUTIC APPLICATIONS | |
| DK3275453T3 (da) | Farmaceutisk sammensætning med silibinin og ve | |
| DK3388085T3 (da) | Farmaceutisk sammensætning og anvendelser deraf |